Showing results (371-380 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|February 28, 2026
Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse modelZiyu Zhang, Man Wang, Fangzhi Tan, et al.Med (New York, N.Y.)|November 8, 2024
Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic responseYufeng Lin, Mingxu Xie, Harry Cheuk-Hay Lau, et al.Med (New York, N.Y.)|November 9, 2024
ADRIATIC: When face value is enoughAlfredo Addeo, Stephen V LiuMed (New York, N.Y.)|May 18, 2022
Closing the gap: How women can benefit more from science, research, policies, and health servicesMehrnoosh Samaei, Marjorie R Jenkins, Alyson J McGregorMed (New York, N.Y.)|May 13, 2026
Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapyXudong Ni, Yufan Zhao, Shanshan Wang, et al.Med (New York, N.Y.)|March 14, 2026
Matching hallmarks of cancer complexity with N-of-1 precision oncologyVivek SubbiahMed (New York, N.Y.)|March 14, 2026
Methodological pitfalls in mild Crohn's disease clinical trialsMaria Manuela Estevinho, Iago Rodríguez-Lago, Sophie Restellini, et al.Med (New York, N.Y.)|February 26, 2026
A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacyYichen Dong, Xuanhao Xu, Haojie Si, et al.Med (New York, N.Y.)|June 12, 2026
Chemoimmunotherapy enables adaptive strategies in locally advanced MSS colorectal cancerFilippo Ghelardi, Filippo PietrantonioMed (New York, N.Y.)|April 12, 2026
Disruptive innovation in breast cancer therapeutic developmentSridatta V Teerdhala, Hannah L Chang, Isaac S ChanPageof 87